Barbara Testoni Selected Research

Hepatitis B e Antigens

10/2023	Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B.
10/2023	Evaluation of the HBV liver reservoir with fine needle aspirates.
1/2021	Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients.
1/2020	Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg-negative chronic hepatitis B.
1/2019	Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.
12/2016	HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara Testoni Research Topics

Disease

19	Infections 05/2024 - 01/2016
11	Chronic Hepatitis B 05/2024 - 08/2013
7	Hepatitis B 04/2024 - 01/2017
5	Hepatocellular Carcinoma (Hepatoma) 10/2019 - 12/2013
4	Persistent Infection 12/2023 - 01/2023
4	Fibrosis (Cirrhosis) 01/2021 - 01/2017
3	Chronic Hepatitis (Chronic Active Hepatitis) 10/2023 - 01/2021
3	Neoplasms (Cancer) 04/2021 - 01/2017
2	Coinfection 04/2024 - 01/2023
2	Disease Progression 11/2022 - 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Liver Diseases (Liver Disease) 01/2020
1	Non-alcoholic Fatty Liver Disease 11/2018
1	Hepatitis C 01/2018
1	Chronic Hepatitis C 01/2018
1	Carcinogenesis 01/2017
1	Neoplasm Metastasis (Metastasis) 12/2013
1	Hyperplasia 08/2007
1	Ectrodactyly 01/2006
1	Cleft Lip (Harelip) 01/2006
1	Ectodermal Dysplasia (Aplasia Cutis Congenita) 01/2006

Drug/Important Bio-Agent (IBA)

11	Antiviral Agents (Antivirals)IBA 06/2023 - 08/2013
9	Hepatitis B Surface Antigens (HBsAg)FDA Link 04/2024 - 08/2013
8	RNA (Ribonucleic Acid)IBA 05/2024 - 12/2016
7	Circular DNAIBA 12/2023 - 08/2013
6	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2006
6	Hepatitis B e AntigensIBA 10/2023 - 12/2016
5	AntigensIBA 04/2024 - 01/2019
4	InterferonsIBA 01/2023 - 12/2016
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2013
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2017
3	ChromatinIBA 01/2022 - 01/2017
2	Viral DNAIBA 01/2022 - 01/2021
2	Nucleic AcidsIBA 01/2021 - 01/2020
2	NucleosidesIBA 12/2020 - 01/2016
2	nasIBA 01/2020 - 01/2017
2	Interferon-alpha (Interferon Alfa)IBA 01/2020 - 01/2017
2	pgRNAIBA 01/2020 - 01/2019
1	selgantolimodIBA 05/2024
1	Conditioned Culture MediaIBA 05/2024
1	Toll-Like Receptor 8IBA 05/2024
1	Tenofovir (Viread)FDA Link 04/2024
1	Immunoglobulins (Immunoglobulin)IBA 06/2023
1	hepatitis B hyperimmune globulinIBA 06/2023
1	Hepatitis delta Antigens (HDAg)IBA 01/2023
1	Histones (Histone)IBA 01/2022
1	Taurocholic Acid (Sodium Taurocholate)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Viral AntigensIBA 04/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Messenger RNA (mRNA)IBA 10/2019
1	Toll-Like Receptor 3IBA 10/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	EnzymesIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 11/2018
1	Hepatitis B Core AntigensIBA 01/2018
1	Surface Antigens (Surface Antigen)IBA 01/2017
1	CytokinesIBA 01/2016
1	Epidermal Growth Factor (EGF)IBA 08/2007
1	MitogensIBA 08/2007

Therapy/Procedure

11	Therapeutics 04/2024 - 08/2013
3	Liver Transplantation 06/2023 - 01/2016
1	Duration of Therapy 10/2023
1	Intravenous Injections 01/2023
1	Aftercare (After-Treatment) 01/2020
1	Retreatment 01/2020
1	Withholding Treatment 01/2016